Skip to main content
Premium Trial:

Request an Annual Quote

Issues to Be Resolved in Genomic Solutions-Harvard Bioscience Merger


How to Make GNSL Profitable: The company had $7.2 million in the bank as of March 31 and was losing $1.5 million per quarter. HBIO said the unit will be immediately profitable after a $1.5 million restructuring charge, but wants to bring it to 20 percent profitability “within a couple of years.”.

Who Stays, Who Goes: GNSL will cut 30 percent of its staff, after 25 percent staff cuts that began last September. Likely to leave: mid- to upper management at GNSL. Likely to stay: sales team. Staying: CEO Jeff Williams; Tom Tisone, founder of Cartesian Technologies; Dave Bayat, Manager of Genomic Solutions’ UK plant.

Trimming GNSL’s Genomics Product Lineup: Proteomics and HTS instruments likely to be emphasized, future uncertain for GeneTAC HybStation, G3 Library Management System, LS IV, and UC4 arraying instruments. License to produce GeneMap microarrays must be renegotiated with Affymetrix.

Coordinating Sales and Distribution Networks: Genomic Solutions has 40 to 45 people in sales, marketing, and field services worldwide, including 25 sales people. Harvard Bioscience has four, including two in Europe and two in the US.

The Future of the GNSL-PerkinElmer relationship: Likely to stay in place if PerkinElmer continues to show improvement in sales.

Schleicher & Schuell’s stake in GNSL. The company owned 29 percent of Cartesian Technologies and now owns 6.25 percent stake in GNSL. But with GNSL being acquired by a Schleicher & Schuell competitor on the supply end, what will S&S do?

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.